Ambu saw the highest growth of 219% in patent filings in November and 199% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 62% and grants by 199%. GlobalData’s DataBook provides a comprehensive analysis of Ambu’s patent filings and grants. Buy the databook here.
Ambu has been focused on protecting inventions in European Patent Office(EPO) with one publication in Q4 2023
The European Patent Office(EPO) patent Office are among the top ten patent offices where Ambu is filings its patents.
Fujifilm could be the strongest competitor for Ambu
Ambu stands in second position with respect to its patent publications among its competitors.
Patents related to healthtech and 3d printing lead Ambu's portfolio
Ambu has the highest number of patents in healthtech followed by, 3d printing and computer vision. For healthtech, nearly 40% of patents were filed and no patents were granted in Q4 2023.
Anesthesia and respiratory devices related patents lead Ambu portfolio followed by television, and image management
Ambu has highest number of patents in anesthesia and respiratory devices followed by television, image management, medical device, and diagnostic imaging. For anesthesia and respiratory devices, nearly 43% of patents were filed and 22% of patents were granted in Q4 2023.
For comprehensive analysis of Ambu's filings and grants, buy the databook here.